VGLL4 is a Novel Regulator of Survival in Human Embryonic Stem Cells

Human embryonic stem cells (hESCs) are maintained in a self-renewing state by an interconnected network of mechanisms that sustain pluripotency, promote proliferation and survival, and prevent differentiation. We sought to find novel genes that could contribute to one or more of these processes by u...

Full description

Saved in:
Bibliographic Details
Published inStem cells (Dayton, Ohio) Vol. 31; no. 12; pp. 2833 - 2841
Main Authors Tajonar, Adriana, Maehr, René, Hu, Guang, Sneddon, Julie B., Rivera-Feliciano, José, Cohen, Dena E., Elledge, Stephen J., Melton, Douglas A.
Format Journal Article
LanguageEnglish
Published 01.12.2013
Online AccessGet full text

Cover

Loading…
More Information
Summary:Human embryonic stem cells (hESCs) are maintained in a self-renewing state by an interconnected network of mechanisms that sustain pluripotency, promote proliferation and survival, and prevent differentiation. We sought to find novel genes that could contribute to one or more of these processes by using a gain-of-function screen of a large collection of human open reading frames. We identified Vestigial-like 4 (VGLL4), a co-transcriptional regulator with no previously described function in hESCs, as a positive regulator of survival in hESCs. Specifically, VGLL4 overexpression in hESCs significantly decreases cell death in response to dissociation stress. Additionally, VGLL4 overexpression enhances hESC colony formation from single cells. These effects may be attributable, in part, to a decreased activity of initiator and effector caspases observed in the context of VGLL4 overexpression. Additionally, we show an interaction between VGLL4 and the Rho/Rock pathway, previously implicated in hESC survival. This study introduces a novel gain-of-function approach for studying hESC maintenance and presents VGLL4 as a previously undescribed regulator of this process.
Bibliography:GH current institution: National Institute of Environmental Health Sciences – National Institutes of Health, Research Triangle Park, North Carolina, USA
RM current institution: Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, USA
ISSN:1066-5099
1549-4918
DOI:10.1002/stem.1445